nach oben

Erschienen in:

19.02.2016 | Original Article

Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis

verfasst von: Elias K. Spanakis, Xu Wang, Brisa N. Sánchez, Ana V. Diez Roux, Belinda L. Needham, Gary S. Wand, Teresa Seeman, Sherita Hill Golden

Erschienen in: Endocrine | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Cross-sectional association has been shown between type 2 diabetes and hypothalamic–pituitary–adrenal (HPA) axis dysregulation; however, the temporality of this association is unknown. Our aim was to determine if type 2 diabetes is associated with longitudinal change in daily cortisol curve features. We hypothesized that the presence of type 2 diabetes may lead to a more blunted and abnormal HPA axis profile over time, suggestive of increased HPA axis dysregulation. This was a longitudinal cohort study, including 580 community-dwelling individuals (mean age 63.7 ± 9.1 years; 52.8 % women) with (n = 90) and without (n = 490) type 2 diabetes who attended two MultiEthnic Study of Atherosclerosis Stress ancillary study exams separated by 6 years. Outcome measures that were collected were wake-up and bedtime cortisol, cortisol awakening response (CAR), total area under the curve (AUC), and early, late, and overall decline slopes. In univariate analyses, wake-up and AUC increased over 6 years more in persons with as compared to those without type 2 diabetes (11 vs. 7 % increase for wake-up and 17 vs. 11 % for AUC). The early decline slope became flatter over time with a greater flattening observed in diabetic compared to non-diabetic individuals (23 vs. 9 % flatter); however, the change was only statistically significant for wake-up cortisol (p-value: 0.03). Over time, while CAR was reduced more, late decline and overall decline became flatter, and bedtime cortisol increased less in those with as compared to those without type 2 diabetes, none of these changes were statistically significant in adjusted models. We did not identify any statistically significant change in cortisol curve features over 6 years by type 2 diabetes status.

Nur mit Berechtigung zugänglich

P.M. Peeke, G.P. Chrousos, Hypercortisolism and obesity. Ann. N. Y. Acad. Sci. 771, 665–676 (1995)CrossRefPubMed

G. Mazziotti, C. Gazzaruso, A. Giustina, Diabetes in cushing syndrome: basic and clinical aspects. TEM 22(12), 499–506 (2011). doi:10.1016/j.tem.2011.09.001 PubMed

P. Anagnostis, V.G. Athyros, K. Tziomalos, A. Karagiannis, D.P. Mikhailidis, Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J. Clin. Endocrinol. Metab. 94(8), 2692–2701 (2009). doi:10.1210/jc.2009-0370 CrossRefPubMed

H. Bruehl, M. Rueger, I. Dziobek, V. Sweat, A. Tirsi, E. Javier, A. Arentoft, O.T. Wolf, A. Convit, Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes. J. Clin. Endocrinol. Metab. 92(7), 2439–2445 (2007). doi:10.1210/jc.2006-2540 CrossRefPubMed

I. Chiodini, M. Torlontano, A. Scillitani, M. Arosio, S. Bacci, S. Di Lembo, P. Epaminonda, G. Augello, R. Enrini, B. Ambrosi, G. Adda, V. Trischitta, Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur. J. Endocrinol. 153(6), 837–844 (2005). doi:10.1530/eje.1.02045 CrossRefPubMed

A.F. Godoy-Matos, A.R. Vieira, R.O. Moreira, W.F. Coutinho, L.M. Carraro, D.M. Moreira, R. Pasquali, R.M. Meirelles, The potential role of increased adrenal volume in the pathophysiology of obesity-related type 2 diabetes. J. Endocrinol. Invest. 29(2), 159–163 (2006)CrossRefPubMed

S. Champaneri, X. Xu, M.R. Carnethon, A.G. Bertoni, T. Seeman, A.S. DeSantis, A. Diez Roux, S. Shrager, S.H. Golden, Diurnal salivary cortisol is associated with body mass index and waist circumference: the multiethnic study of atherosclerosis. Obesity 21(1), E56–E63 (2013). doi:10.1002/oby.20047 CrossRefPubMedPubMedCentral

R. Rosmond, S. Wallerius, P. Wanger, L. Martin, G. Holm, P. Bjorntorp, A 5-year follow-up study of disease incidence in men with an abnormal hormone pattern. J. Intern. Med. 254(4), 386–390 (2003)CrossRefPubMed

A. Gungunes, M. Sahin, T. Demirci, B. Ucan, E. Cakir, M.S. Arslan, I.O. Unsal, B. Karbek, M. Caliskan, M. Ozbek, E. Cakal, T. Delibasi, Cushing’s syndrome in type 2 diabetes patients with poor glycemic control. Endocrine 47(3), 895–900 (2014). doi:10.1007/s12020-014-0260-8 CrossRefPubMed

10.

B. Catargi, V. Rigalleau, A. Poussin, N. Ronci-Chaix, V. Bex, V. Vergnot, H. Gin, P. Roger, A. Tabarin, Occult Cushing’s syndrome in type-2 diabetes. J. Clin. Endocrinol. Metab. 88(12), 5808–5813 (2003). doi:10.1210/jc.2003-030254 CrossRefPubMed

11.

L. Wei, T.M. MacDonald, B.R. Walker, Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann. Intern. Med. 141(10), 764–770 (2004)CrossRefPubMed

12.

P.C. Souverein, A. Berard, T.P. Van Staa, C. Cooper, A.C. Egberts, H.G. Leufkens, B.R. Walker, Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 90(8), 859–865 (2004). doi:10.1136/hrt.2003.020180 CrossRefPubMedPubMedCentral

13.

J. Etxabe, J.A. Vazquez, Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin. Endocrinol. 40(4), 479–484 (1994)CrossRef

14.

N.M. Neary, O.J. Booker, B.S. Abel, J.R. Matta, N. Muldoon, N. Sinaii, R.I. Pettigrew, L.K. Nieman, A.M. Gharib, Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography. J. Clin. Endocrinol. Metab. 98(5), 2045–2052 (2013). doi:10.1210/jc.2012-3754 CrossRefPubMedPubMedCentral

15.

S. Champaneri, G.S. Wand, S.S. Malhotra, S.S. Casagrande, S.H. Golden, Biological basis of depression in adults with diabetes. Curr. Diab. Rep. 10(6), 396–405 (2010). doi:10.1007/s11892-010-0148-9 CrossRefPubMed

16.

P.E. Szmitko, C.H. Wang, R.D. Weisel, J.R. de Almeida, T.J. Anderson, S. Verma, New markers of inflammation and endothelial cell activation: part I. Circulation 108(16), 1917–1923 (2003). doi:10.1161/01.CIR.0000089190.95415.9F CrossRefPubMed

17.

P.M. Ridker, J.E. Buring, J. Shih, M. Matias, C.H. Hennekens, Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98(8), 731–733 (1998)CrossRefPubMed

18.

J.C. Pruessner, O.T. Wolf, D.H. Hellhammer, A. Buske-Kirschbaum, K. von Auer, S. Jobst, F. Kaspers, C. Kirschbaum, Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 61(26), 2539–2549 (1997)CrossRefPubMed

19.

C. Kirschbaum, D.H. Hellhammer, Salivary cortisol in psychobiological research: an overview. Neuropsychobiology 22(3), 150–169 (1989).CrossRefPubMed

20.

A.S. Karlamangla, E.M. Friedman, T.E. Seeman, R.S. Stawksi, D.M. Almeida, Daytime trajectories of cortisol: demographic and socioeconomic differences—findings from the National Study of Daily Experiences. Psychoneuroendocrinology 38(11), 2585–2597 (2013). doi:10.1016/j.psyneuen.2013.06.010 CrossRefPubMed

21.

S.E. Sephton, R.M. Sapolsky, H.C. Kraemer, D. Spiegel, Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer Inst. 92(12), 994–1000 (2000)CrossRefPubMed

22.

E.K. Adam, M.R. Gunnar, Relationship functioning and home and work demands predict individual differences in diurnal cortisol patterns in women. Psychoneuroendocrinology 26(2), 189–208 (2001)CrossRefPubMed

23.

M.R. Gunnar, D.M. Vazquez, Low cortisol and a flattening of expected daytime rhythm: potential indices of risk in human development. Dev. Psychopathol. 13(3), 515–538 (2001)CrossRefPubMed

24.

S.R. Kunz-Ebrecht, C. Kirschbaum, M. Marmot, A. Steptoe, Differences in cortisol awakening response on work days and weekends in women and men from the Whitehall II cohort. Psychoneuroendocrinology 29(4), 516–528 (2004)CrossRefPubMed

25.

C.E. Wright, A. Steptoe, Subjective socioeconomic position, gender and cortisol responses to waking in an elderly population. Psychoneuroendocrinology 30(6), 582–590 (2005). doi:10.1016/j.psyneuen.2005.01.007 CrossRefPubMed

26.

S. Cohen, J.E. Schwartz, E. Epel, C. Kirschbaum, S. Sidney, T. Seeman, Socioeconomic status, race, and diurnal cortisol decline in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Psychosom. Med. 68(1), 41–50 (2006). doi:10.1097/01.psy.0000195967.51768.ea CrossRefPubMed

27.

D.E. Saxbe, R.L. Repetti, A. Nishina, Marital satisfaction, recovery from work, and diurnal cortisol among men and women. Health Psychol. 27(1), 15–25 (2008). doi:10.1037/0278-6133.27.1.15 CrossRefPubMed

28.

A. Hajat, A. Diez-Roux, T.G. Franklin, T. Seeman, S. Shrager, N. Ranjit, C. Castro, K. Watson, B. Sanchez, C. Kirschbaum, Socioeconomic and race/ethnic differences in daily salivary cortisol profiles: the multi-ethnic study of atherosclerosis. Psychoneuroendocrinology 35(6), 932–943 (2010). doi:10.1016/j.psyneuen.2009.12.009 CrossRefPubMedPubMedCentral

29.

M. Kumari, M. Shipley, M. Stafford, M. Kivimaki, Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality: findings from the Whitehall II study. J. Clin. Endocrinol. metab. 96(5), 1478–1485 (2011). doi:10.1210/jc.2010-2137 CrossRefPubMedPubMedCentral

30.

X. Wang, B.N. Sanchez, S.H. Golden, S. Shrager, C. Kirschbaum, A.S. Karlamangla, T.E. Seeman, A.V. Roux, Stability and predictors of change in salivary cortisol measures over six years: MESA. Psychoneuroendocrinology 49, 310–320 (2014). doi:10.1016/j.psyneuen.2014.07.024 CrossRefPubMedPubMedCentral

31.

S.H. Golden, B.N. Sanchez, M. Wu, S. Champaneri, A.V. Diez Roux, T. Seeman, G.S. Wand, Relationship between the cortisol awakening response and other features of the diurnal cortisol rhythm: the Multi-Ethnic Study of Atherosclerosis. Psychoneuroendocrinology 38(11), 2720–2728 (2013). doi:10.1016/j.psyneuen.2013.06.032 CrossRefPubMed

32.

S.H. Golden, G.S. Wand, S. Malhotra, I. Kamel, K. Horton, Reliability of hypothalamic-pituitary-adrenal axis assessment methods for use in population-based studies. Eur. J. Epidemiol. 26(7), 511–525 (2011). doi:10.1007/s10654-011-9585-2 CrossRefPubMedPubMedCentral

33.

G. Tirabassi, M. Boscaro, G. Arnaldi, Harmful effects of functional hypercortisolism: a working hypothesis. Endocrine 46(3), 370–386 (2014). doi:10.1007/s12020-013-0112-y CrossRefPubMed

34.

J.J. Joseph, X. Wang, E. Spanakis, T. Seeman, G. Wand, B. Needham, S.H. Golden, Diurnal salivary cortisol, glycemia and insulin resistance: the multi-ethnic study of atherosclerosis. Psychoneuroendocrinology 62, 327–335 (2015). doi:10.1016/j.psyneuen.2015.08.021 CrossRefPubMed

35.

D.E. Bild, D.A. Bluemke, G.L. Burke, R. Detrano, A.V. Diez Roux, A.R. Folsom, P. Greenland, D.R. Jacob Jr, R. Kronmal, K. Liu, J.C. Nelson, D. O’Leary, M.F. Saad, S. Shea, M. Szklo, R.P. Tracy, Multi-ethnic study of atherosclerosis: objectives and design. Am. J. Epidemiol. 156(9), 871–881 (2002)CrossRefPubMed

36.

H. Raff, Update on late-night salivary cortisol for the diagnosis of Cushing’s syndrome: methodological considerations. Endocrine 44(2), 346–349 (2013). doi:10.1007/s12020-013-0013-0 CrossRefPubMed

37.

G. Bellastella, M.I. Maiorino, A. De Bellis, M.T. Vietri, C. Mosca, L. Scappaticcio, D. Pasquali, K. Esposito, D. Giugliano, Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes. Endocrine (2015). doi:10.1007/s12020-015-0777-5

38.

S. Hill Golden, B.N. Sanchez, A.S. Desantis, M. Wu, C. Castro, T.E. Seeman, S. Tadros, S. Shrager, A.V. Diez Roux, Salivary cortisol protocol adherence and reliability by socio-demographic features: the Multi-Ethnic Study of Atherosclerosis. Psychoneuroendocrinology 43, 30–40 (2014). doi:10.1016/j.psyneuen.2014.01.025 CrossRefPubMed

39.

D.H. Hellhammer, S. Wust, B.M. Kudielka, Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology 34(2), 163–171 (2009). doi:10.1016/j.psyneuen.2008.10.026 CrossRefPubMed

40.

K.C. Yeh, K.C. Kwan, A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation. J. Pharmacokinet. Biopharm. 6(1), 79–98 (1978)CrossRefPubMed

41.

E. Badrick, C. Kirschbaum, M. Kumari, The relationship between smoking status and cortisol secretion. J. Clin. Endocrinol. metab. 92(3), 819–824 (2007). doi:10.1210/jc.2006-2155 CrossRefPubMed

42.

A.G. Bertoni, M.C. Whitt-Glover, H. Chung, K.Y. Le, R.G. Barr, M. Mahesh, N.S. Jenny, G.L. Burke, D.R. Jacobs, The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Am. J. Epidemiol. 169(4), 444–454 (2009). doi:10.1093/aje/kwn350 CrossRefPubMed

43.

L. Radloff, The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1, 385–401 (1977)CrossRef

44.

P.A. Pilkonis, S.D. Imber, P. Rubinsky, Dimensions of life stress in psychiatric patients. J. Human Stress 11(1), 5–10 (1985). doi:10.1080/0097840X.1985.9936732 CrossRefPubMed

45.

M.S. Mujahid, A.V. Diez Roux, R.C. Cooper, S. Shea, D.R. Williams, Neighborhood stressors and race/ethnic differences in hypertension prevalence (the Multi-Ethnic Study of Atherosclerosis). Am. J. Hypertens. 24(2), 187–193 (2011). doi:10.1038/ajh.2010.200 CrossRefPubMed

46.

E.K. Adam, M. Kumari, Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology 34(10), 1423–1436 (2009). doi:10.1016/j.psyneuen.2009.06.011 CrossRefPubMed

47.

S. Champaneri, X. Xu, M.R. Carnethon, A.G. Bertoni, T. Seeman, A. Diez Roux, S.H. Golden, Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis. Metabolism 61(7), 986–995 (2012). doi:10.1016/j.metabol.2011.11.006 CrossRefPubMed

48.

G. Casella, R. Berger, Statistical Inference, vol. 2 (Duxbury Press, Pacific Grove, 2001)

49.

H. Bruehl, O.T. Wolf, A. Convit, A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus. Psychoneuroendocrinology 34(6), 815–821 (2009). doi:10.1016/j.psyneuen.2008.12.010 CrossRefPubMedPubMedCentral

50.

F. Lederbogen, J. Hummel, C. Fademrecht, B. Krumm, C. Kuhner, M. Deuschle, K.H. Ladwig, C. Meisinger, H.E. Wichmann, H. Lutz, B. Breivogel, Flattened circadian cortisol rhythm in type 2 diabetes. Exp. Clin. Endocrinol. Diabet. 119(9), 573–575 (2011). doi:10.1055/s-0031-1275288 CrossRef

51.

S.A. Vreeburg, B.P. Kruijtzer, J. van Pelt, R. van Dyck, R.H. DeRijk, W.J. Hoogendijk, J.H. Smit, F.G. Zitman, B.W. Penninx, Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology. Psychoneuroendocrinology 34(8), 1109–1120 (2009). doi:10.1016/j.psyneuen.2009.04.024 CrossRefPubMed

52.

R.A. Hackett, A. Steptoe, M. Kumari, Association of diurnal patterns in salivary cortisol with type 2 diabetes in the Whitehall II study. J. Clin. Endocrinol. metab. (2014). doi:10.1210/jc.2014-2459 PubMedPubMedCentral

Titel: Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis
verfasst von: Elias K. Spanakis
Xu Wang
Brisa N. Sánchez
Ana V. Diez Roux
Belinda L. Needham
Gary S. Wand
Teresa Seeman
Sherita Hill Golden
Publikationsdatum: 19.02.2016
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 1/2016
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-016-0887-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2016

Combined use of conventional smear and liquid-based preparation versus conventional smear for thyroid fine-needle aspiration

Erratum to: The treatment with pasireotide in Cushing’s disease: effects of long–term treatment on tumor mass in the experience of a single center

CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation

Free vitamin D does not vary through the follicular phase of the menstrual cycle

Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy

Undercarboxylated osteocalcin is associated with insulin resistance, but not adiponectin, during pregnancy

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin